Contact Us

DESTINATION NEWS

Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR

Sep 4, 2024

AI-based tumor microenvironment classification utilizingLunit SCOPE IO® shows promise for guiding treatment decisions in advanced BTC

Emeren Appoints Dr. Ramki Srinivasan to Its Board of Directors

Sep 4, 2024

STAMFORD,Conn.,Sept. 3,2024-- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL),a leading global solar project developer,owner,and operator,today announced

HSG Laser Marks Four Years of Innovation of Tokyo R&D Center, Leading the Way in Fiber Laser Cutting Technology

Sep 4, 2024

TOKYO,Sept. 3,2024-- HSG Laser,a leading global provider of metal shaping equipment and solutions,proudly marks the fourth anniversary of its Global R&D Center in Tokyo,Japan. This significant mil

UPPAbaby Unveils New Strollers at Kind + Jugend, Enhancing Every Journey of Parenthood

Sep 4, 2024

Minu V3 and Minu Duo: Travel Solutions Designed for Today\'s Modern Families ROCKLAND,Mass.,Sept. 3,2024-- UPPAbaby,the brand that embodies the "Parenthood,Understood" philosophy is excited

Axcelis Announces Sponsorship and Participation in The International Conference on Ion Implantation Technology 2024 in Toyoma, Japan

Sep 4, 2024

BEVERLY,Mass.,Sept. 4,2024-- Axcelis Technologies,Inc. (NASDAQ: ACLS),a leading supplier of enabling ion implantation solutions for the semiconductor industry,will be a top-level Platinum Sponsor at

Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma

Sep 4, 2024

SAN FRANCISCOand SUZHOU,China,Sept. 4,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua

1 ... 301 302 303 304 305 306 307 ... 357